Cystadane

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 52276-400
  • Package NDC 52276-400-01
  • Application number NDA020576
  • SPL ID 3a4fdd66-b72b-4aa3-94bb-bac8af98b150
  • SPL set ID 31a684d0-cd98-4e46-b43a-ccbd17c41559
  • UNII 3SCV180C9W
  • RxCUI 404539
  • RxCUI 562847

What the source publishes

Labeler
Recordati Rare Diseases
Active ingredients
betaine
Form
POWDER, FOR SOLUTION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:52276-400_3a4fdd66-b72b-4aa3-94bb-bac8af98b150
{
  "name": "Cystadane",
  "splId": "3a4fdd66-b72b-4aa3-94bb-bac8af98b150",
  "labels": [
    {
      "setId": "31a684d0-cd98-4e46-b43a-ccbd17c41559",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31a684d0-cd98-4e46-b43a-ccbd17c41559",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=31a684d0-cd98-4e46-b43a-ccbd17c41559"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Recordati Rare Diseases",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "180 g in 1 BOTTLE (52276-400-01)",
      "package_ndc": "52276-400-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20170413"
    }
  ],
  "productId": "52276-400_3a4fdd66-b72b-4aa3-94bb-bac8af98b150",
  "useDomain": "unknown",
  "dosageForm": "POWDER, FOR SOLUTION",
  "productNdc": "52276-400",
  "deaSchedule": null,
  "genericName": "betaine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BETAINE",
      "strength": "1 g/g"
    }
  ],
  "applicationNumber": "NDA020576",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "19961025",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175804",
      "N0000175805"
    ],
    "unii": [
      "3SCV180C9W"
    ],
    "rxcui": [
      "404539",
      "562847"
    ],
    "spl_set_id": [
      "31a684d0-cd98-4e46-b43a-ccbd17c41559"
    ],
    "pharm_class_epc": [
      "Methylating Agent [EPC]"
    ],
    "pharm_class_moa": [
      "Methylating Activity [MoA]"
    ],
    "manufacturer_name": [
      "Recordati Rare Diseases"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:52276-400_3a4fdd66-b72b-4aa3-94bb-bac8af98b150"